Integrating China in the International Consortium for Personalised Medicine: a position paper on innovation and digitalization in Personalized Medicine

• Published in: BMC public health Vol. 24; no. 1; p. 464
• Main Authors: Beccia, Flavia, Di Marcantonio, Marzia, Causio, Francesco Andrea, Schleicher, Lena, Wang, Lili, Cadeddu, Chiara, Ricciardi, Walter, Boccia, Stefania
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 14.02.2024; BioMed Central; BMC
• Subjects: Big Data; China; Collaboration; Consortia; Cooperation; Customization; Data integrity; Data management; Delivery of Health Care; Digitization; Effectiveness; European Union; funding; Health aspects; Health care; Humans; ICT solutions; Industrialized nations; Information management; Innovation; Innovations; International cooperation; Interoperability; Management; Medical laboratory technology; Medical technology; Medicine; New technology; Precision Medicine; Priorities; R&D; Research & development; Resource allocation; Security; Security management; Surveys; Sustainability; Sustainable development; Workshops; China; Europe; Innovation; funding; ICT solutions; European Union; China; Big Data; Personalised medicine
• ISSN: 1471-2458; 1471-2458
• DOI: 10.1186/s12889-024-18009-8

The advent of Personalized Medicine (PM) holds significant promise in revolutionizing healthcare by tailoring treatments to individual patients based on their data. However, its successful implementation requires the seamless integration of innovative technologies and presents formidable challenges in terms of sustainability. To tackle these challenges head-on, the International Consortium for Personalized Medicine (ICPerMed) was established, and the IC2PerMed project, as part of this consortium, seeks to foster collaboration between the European Union (EU) and China in the field of Personalized Medicine. Based on the results collected by the project, the objective of this study is to discern the key priorities for the implementation of Personalised Medicine concerning Information and Communication Technologies (ICT) and Big Data and digital solutions, with a particular emphasis on data management and protection. A Delphi survey was conducted to gather expert's consensus on the main priorities for actions on Information and Communication Technologies (ICT) and Big Data and digital solutions in the field of Personalized Medicine. The survey identified seven priorities in the area of Big Data and digital solutions, including data interoperability, standards, security measures, and international partnerships. Additionally, twelve priorities were identified for the innovation-to-market process, emphasizing cost-effectiveness, need assessment, and value definition in resource allocation. The effective implementation of new technologies in Personalized Medicine research and practice is essential for the advancement of healthcare systems in both the European and Chinese contexts. The identified priorities play a pivotal role in promoting the sustainability of health systems and driving innovation in the implementation of Personalized Medicine. Addressing challenges related to data interoperability, standards, security, international collaboration, cost-effectiveness, and value assessment is of utmost importance in order to propel the progress of Personalized Medicine in healthcare systems.